| Literature DB >> 22666835 |
Sônia Saeger Meireles1, Silvia Terra Fontes, Luiz Antônio Afonso Coimbra, Álvaro Della Bona, Flávio Fernando Demarco.
Abstract
OBJECTIVES: This in vitro study evaluated the effectiveness of three carbamide peroxide concentrations used for tooth bleaching treatments.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22666835 PMCID: PMC3894761 DOI: 10.1590/s1678-77572012000200011
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Color scores by sequence of colors in the shade guide (from lighter to darker colors)
| Scores | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 |
Description of the bleaching agents used in this study
| Whiteness Perfect 10% | FGM, Joinville,SC, Brazil | 10% carbamide peroxide, carbopol, potassiumnitrate, sodium fluoride, glycol and deionized water. |
| Whiteness Perfect 16% | FGM, Joinville, SC, Brazil | 16% carbamide peroxide, carbopol, potassiumnitrate, sodium fluoride, glycol and deionized water. |
| Whiteness Super 37% | FGM, Joinville, SC, Brazil | 37% carbamide peroxide, carbopol, potassium ions,glycol and deionized water. |
Tooth shade means and standard deviations (±SD) for the different treatment groups according to the evaluation periods
| Control | A12.9 (±1.7)a | A12.4 (±1.3)a | A 12.5 (±0.7)a |
| CP10 | A12.7 (±2.6)a | B4.4 (±2.1)b | C2.9 (±0.7)b |
| CP16 | A12.7 (±1.8)a | B4.1 (±2.2)b | C2.3 (±1.3)b |
| CP37 | A11.8 (±2.5)a | B7.0 (±3.2)c | C2.4 (±0.6)b |
Different capital letters indicate statistically significant differences only among the evaluation periods (p<0.001). Different lowercase letters indicate statistically significant differences only among the treatment groups (p<0.001).
Tooth color parameter means and standard deviations (±SD) for the different treatment groups according to the evaluation periods
| ΔL* | Control | A 77.2 (±4.2)a | B 1.9 (±2.4)a | B 2.4 (±3.0)a |
| CP10 | A 76.4 (±4.5)a | B 10.1 (±4.2)b | C 12.1 (±5.6)b | |
| CP16 | A 75.6 (±4.2)a | B 12.6 (±3.7)b | C 15.6 (±6.7)b | |
| CP37 | A 79.3 (±2.8)a | B 5.9 (±2.2)c | B 6.2 (±2.3)c | |
| Δa* | Control | A 2.5 (±2.3)a | B -1.0 (±0.8)a | C -1.7 (±1.6)a |
| CP10 | A 2.4 (±2.9)a | B -2.6 (±1.9)b | B -2.7 (±2.1)a | |
| CP16 | A 1.7 (±2.1)a | B - 2.5 (±1.5)b | B - 2.3 (±1.4)a | |
| CP37 | A 2.5 (±2.4)a | B -2.8 (±2.0)b | C -3.4 (±1.9)a | |
| Δb* | Control | A 36.4 (±5.0)a | B -1.4 (±1.9)a | C -2.7 (±3.4)a |
| CP10 | A 36.1 (±4.2)a | B - 7.6 (±3.1)b | B -7.6 (±2.2)b | |
| CP16 | A 32.0 (±4.0)a | B - 5.8 (±3.4)b | B -5.0 (±3.3)ab | |
| CP37 | A 36.0 (±5.2)a | B - 7.1 (±4.1)b | C - 11.0 (±4.0)c | |
| ΔE | Control | — | A 3.6 (±1.9)a | B 5.5 (±2.9)a |
| CP10 | — | A 13.5 (±3.9)b | A 15.1 (±5.0)b | |
| CP16 | --- | A 14.4 (±3.9)b | B 16.8 (±4.1)b | |
| CP37 | --- | A 10.1 (±3.9)c | B 13.6 (±3.5)b | |
At baseline, L*, a*, b* means were shown in absolute values. Different capital letters indicate statistical significant differences only between evaluation periods (p<0.05). Different lowercase letters indicate statistical significant differences only between treatment groups (p<0.05).